Red blood cell (RBC) alpha-tocopherol and fatty acid levels in children undergoing long-term antiepileptic therapy were examined. Antiepileptic drugs included diphenylhydantoin (PHT), valproic acid (YPA), phenobarbital (PB), and carbamazepine (CBZ). RBC alpha tocopherol levels were low in patients receiving multi-drug combination therapy, as compared with children receiving no treatment (controls), but plasma alpha-tocopherol levels were the same in both groups. With respect to fatty acid composition in RBCs, docosahexaenoic acid (DHA) level was decreased in children receiving antiepileptic therapy, while no changes were documented in the other fatty acids.
It has been found that children receiving long-term antiepileptic therapy occasionally experience unfavorable side effects including an impairment of folic acid metabolism (1, 2) and the development of osteomalacia (rickets) (3, 4) , as well as allergic discomfort (urticarias or Stevens-Johnson syndrome). The metabolic disturbances associated with therapy seem mainly to involve peroxidative damages relating to detoxification mechanisms including the mixed oxidase functions in liver microsomes (5, 6) . It also appears that this therapy may disturb metabolisms of vitamin E, as there have been a few reports that serum vitamin E levels were reduced in children receiving long-term antiepileptic treatment (7) (8) (9) . However, to our knowledge, the influence of long-term antiepileptic therapy on cell or tissue tocopherol concentrations has not yet been clearly defined. This study was attempted to clarify whether or not long-term anticonvalsant therapy in epileptic children affects RBC tocopherol levels, and/or the fatty acid compositions in RBC membranes. particular AEDs they had been given, but RBC tocopherol levels were lowest in the patients who were given PHT or PB, or a combination of various AEDs (Poly-ph group). Findings of plasma tocopherol levels in this study differ from those in previous reports (7-9) which showed lower plasma tocopherol levels in children re ceiving AED therapy, as compared with controls. Since it is well known that plasma tocopherol level easily reflects plasma lipid level (13), the discrepancy with regard to plasma tocopherol levels may be attributable to the influence of plasma lipids in the patients. Given that the nutritional status of vitamin E has been reported to be reflected in RBC tocopherol levels in our previous studies (10, 13, 14) , the finding of low RBC tocopherol levels in the children who were given AEDs in this study may be consistent with a hypothesis previously made on the basis of plasma tocopherol changes. That is, tocopherol exhaustion may occur in these children who were given drugs, because of increased peroxidation associated with an enhanced detoxification metabolism with NADPH-dependent electron transporting, as is known to occur in mixed oxidase functions in liver microsomes (5, 6) . This metabolism produces large numbers of oxygen radicals which may consume tocopherol in the associated membranes. It has been previously reported that in hyperlipemic rats a reduction of RBC tocopherol is accompanied by a similar reduction of microsomal tocopherol in the liver (14) . Thus, the finding of a decrease in RBC tocopherol levels of the children receiving antiepileptic therapy may reflect the reduction of tocopherol content of liver microsomal membranes, where the detoxification metabolism is usually enhanced in these children. 2. Fatty acid composition RBC fatty acid composition was also measured in the AED and control group. As shown in Table 2 , the only difference observed was with docosahexaenoic acid (DHA, C22:6), which was decreased in all the AED groups, as compared with the control. Other fatty acid compositions were not significantly different between the AED and control groups. The relationship between duration of AED therapy and fatty acid changes in the RBCs is shown in Table 3 . RBC DHA was lower in the long-term group who were given AEDs for more than 3 years than in the shorter term group who were given AEDs for 3 years or less. This shorter term group's DHA level was comparable to that of the controls. Infante (15) has indicated that vitamin E and selenium play a role in the desaturation of n-3 and n-6 polyunsaturated fatty acids (PUFAs), by participating in the microsomal electron transport chain and in a proposed peroxidase moiety of the desaturase complex. A decrease in tocopherol content of liver microsomes metabolizing AEDs for a long time may cause the reduction of the desaturase function resulting in the decrease of DHA. However, it is unlikely that increased peroxidation in liver microsomes due to drug detoxification directly relates to the reduction of DHA, because no changes were documented in the other PUFAs in the membrane lipids of children receiving long-term AED therapy.
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